Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Olga Katzendorn"'
Autor:
Olga Katzendorn, Inga Peters, Natalia Dubrowinskaja, Hossein Tezval, Pouriya Faraj Tabrizi, Christoph A. von Klot, Jörg Hennenlotter, Marcel Lafos, Markus A. Kuczyk, Jürgen Serth
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background DNA methylation is frequently observed in the development and progression of many human tumors as well as renal cell cancer (RCC). Tumor Associated Calcium Signal Transducer 2 (TACSTD2) participates in cell cycle progression throu
Externí odkaz:
https://doaj.org/article/177404d0eda24c7eb89204fddace0e08
Autor:
Olga Katzendorn, Christoph A J von Klot, Samy Mahjoub, Pouriya Faraj Tabrizi, Nina N Harke, Hossein Tezval, Susanne Hellms, Jörg Hennenlotter, Mirza S Baig, Arnulf Stenzl, Ferdinand Seith, Marcel Lafos, Markus A Kuczyk, Steffen Rausch, Inga Peters
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0271981 (2022)
Available tests to detect clinically significant prostate cancer frequently lead to overdiagnosis and overtreatment. Our study assessed the feasibility of combining a urinary biomarker-based risk score (SelectMDx®) and multiparametric MRI outcomes i
Externí odkaz:
https://doaj.org/article/ceafe639f0a740e79b64ecad149effb7
Autor:
Jürgen Serth, Inga Peters, Olga Katzendorn, Tu N. Dang, Joana Moog, Zarife Balli, Christel Reese, Jörg Hennenlotter, Alexander Grote, Marcel Lafos, Hossein Tezval, Markus A. Kuczyk
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 19, p 11190 (2022)
Approximately 21% of patients with renal cell cancer (RCC) present with synchronous metastatic disease at the time of diagnosis, and metachronous metastatic disease occurs in 20–50% of cases within 5 years. Recent advances in adjuvant treatment of
Externí odkaz:
https://doaj.org/article/6ad8446110864c269d45f7cbef0bcbd2
Autor:
Margarete Teresa Walach, Frank Schiefelbein, Andreas Schneller, Georg Schoen, Christoph A.J. von Klot, Olga Katzendorn, Julia Mühlbauer, Philipp Nuhn, Maximilian Christian Kriegmair, Nina Natascha Harke
Publikováno v:
Urologia Internationalis. 107:126-133
Introduction: To assess influencing factors on perinephric toxic fat (high Mayo Adhesive Probability [MAP] score) and the impact of high MAP scores on surgical complexity, perioperative outcome, and surgical approach in patients with localized renal
Autor:
Nina N. Harke, Sarah Strauss, Inga Peters, Olga Katzendorn, Hossein Tezval, Markus A. Kuczyk, Peter M. Vogt
Publikováno v:
World Journal of Urology.
Publikováno v:
Journal of Urology. 207
Autor:
Nina N. Harke, Frank Schiefelbein, Andreas Schneller, Georg Schoen, Olga Katzendorn, Christoph A.J. von Klot, Julia K. Mühlbauer, Philipp Nuhn, Maximilian C. Kriegmair, Margarete T. Walach
Publikováno v:
Journal of Urology. 207
Autor:
Markus A. Kuczyk, Natalia Dubrowinskaja, Hossein Tezval, Olga Katzendorn, Jürgen Serth, Inga Peters, Pouriya Faraj Tabrizi, Jörg Hennenlotter, Marcel Lafos, Christoph A. J. von Klot
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Cancer
BMC Cancer
Background DNA methylation is frequently observed in the development and progression of many human tumors as well as renal cell cancer (RCC). Tumor Associated Calcium Signal Transducer 2 (TACSTD2) participates in cell cycle progression through MAPK s
Autor:
Olga Katzendorn, Inga Peters, Natalia Dubrowinskaja, Joana M. Moog, Christel Reese, Hossein Tezval, Pouriya Faraj Tabrizi, Jörg Hennenlotter, Marcel Lafos, Markus A. Kuczyk, Jürgen Serth
Publikováno v:
Cancers
Cancers; Volume 14; Issue 1; Pages: 39
Cancers, Vol 14, Iss 39, p 39 (2022)
Cancers; Volume 14; Issue 1; Pages: 39
Cancers, Vol 14, Iss 39, p 39 (2022)
Simple Summary Early prediction of aggressive cancer using biomarkers is thought to be important for future improvements in the personalized treatment of renal cell carcinoma (RCC). Epigenetic alterations, such as DNA methylation, are promising candi
Autor:
Martin J.P. Hennig, Mario W. Kramer, Hans Kreipe, Tomasz Ozimek, Franz F Dressler, Olga Katzendorn, Sven Perner, Christoph A. J. von Klot, Markus A. Kuczyk, Marie C. Hupe, Judith Riccarda Wießmeyer, Axel S. Merseburger, Julian P. Struck
Publikováno v:
Advances in Therapy
Introduction For risk stratification of non-muscle invasive bladder cancer (NMIBC), the depth of stromal invasion can be further classified, where the lamina muscularis mucosae (MM) serves as a reference structure. While the overall identifiability o